Administration of Pre-Operative Gabapentin to Patients Undergoing Laparoscopy
Gabapentin
1 other identifier
interventional
112
1 country
1
Brief Summary
The purpose of this study is to prospectively determine the influence of immediate pre-operative gabapentin administration on acute postoperative pain. The investigators hypothesize that immediate post-operative pain will be improved with pre-operative administration of gabapentin.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4 postoperative-pain
Started Jun 2015
Typical duration for phase_4 postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 4, 2015
CompletedFirst Posted
Study publicly available on registry
February 9, 2015
CompletedStudy Start
First participant enrolled
June 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2017
CompletedResults Posted
Study results publicly available
March 12, 2018
CompletedMarch 12, 2018
March 1, 2018
1.6 years
February 4, 2015
February 6, 2018
March 8, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
NRS (Numerical Rating Scale)
The NRS is a numerical scale ranging from 0-10 implemented with adults. Having no pain is rated as a 0 and the worst pain the patient could tolerate is rated as a 10.
2-8 hours
Secondary Outcomes (2)
VAS (Visual Analog Scale)
2 -6 hours
Total Morphine Consumption
12 hours post-operatively
Study Arms (2)
Drug 1
EXPERIMENTALPatients will receive Gabapentin 300mg tab less than 1 hour before surgery.
Drug 2
PLACEBO COMPARATORPatients will receive Methylcellulose based placebo tab less than 1 hour before surgery.
Interventions
Patients will receive Gabapentin 300mg tab less than 1 hour before surgery.
Eligibility Criteria
You may qualify if:
- The patient must be female and planning to have a laparoscopic or robotic assisted procedure for benign gynecologic indications.
- Patients must be treated in the department of Obstetrics and Gynecology in the division of Minimally Invasive Gynecologic Surgery.
- The patient must be in the age range of 18-80 years, in general good health and able to comply with study procedures.
You may not qualify if:
- Male patients will be excluded from this study.
- Patients under 18 years old will be excluded from this study.
- Pregnant patients. All patients will have a routine pre-operative urine HCG to exclude pregnancy.
- Patients having abdominal, vaginal or hysteroscopic procedures
- Allergy to gabapentin
- Chronic use of gabapentin (greater than 6 months)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Penn State Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
Related Publications (9)
Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS, Spiegel G, Barakat R, Pearl ML, Sharma SK. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. J Clin Oncol. 2009 Nov 10;27(32):5331-6. doi: 10.1200/JCO.2009.22.3248. Epub 2009 Oct 5.
PMID: 19805679BACKGROUNDManwaring JM, Readman E, Maher PJ. The effect of heated humidified carbon dioxide on postoperative pain, core temperature, and recovery times in patients having laparoscopic surgery: a randomized controlled trial. J Minim Invasive Gynecol. 2008 Mar-Apr;15(2):161-5. doi: 10.1016/j.jmig.2007.09.007.
PMID: 18312984BACKGROUNDOtt DE, Reich H, Love B, McCorvey R, Toledo A, Liu CY, Syed R, Kumar K. Reduction of laparoscopic-induced hypothermia, postoperative pain and recovery room length of stay by pre-conditioning gas with the Insuflow device: a prospective randomized controlled multi-center study. JSLS. 1998 Oct-Dec;2(4):321-9.
PMID: 10036122BACKGROUNDSills GJ. The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol. 2006 Feb;6(1):108-13. doi: 10.1016/j.coph.2005.11.003. Epub 2005 Dec 22.
PMID: 16376147BACKGROUNDHartrick CT, Kovan JP, Shapiro S. The numeric rating scale for clinical pain measurement: a ratio measure? Pain Pract. 2003 Dec;3(4):310-6. doi: 10.1111/j.1530-7085.2003.03034.x.
PMID: 17166126BACKGROUNDClarke H, Bonin RP, Orser BA, Englesakis M, Wijeysundera DN, Katz J. The prevention of chronic postsurgical pain using gabapentin and pregabalin: a combined systematic review and meta-analysis. Anesth Analg. 2012 Aug;115(2):428-42. doi: 10.1213/ANE.0b013e318249d36e. Epub 2012 Mar 13.
PMID: 22415535BACKGROUNDAlayed N, Alghanaim N, Tan X, Tulandi T. Preemptive use of gabapentin in abdominal hysterectomy: a systematic review and meta-analysis. Obstet Gynecol. 2014 Jun;123(6):1221-1229. doi: 10.1097/AOG.0000000000000289.
PMID: 24807337BACKGROUNDAlkhamesi NA, Peck DH, Lomax D, Darzi AW. Intraperitoneal aerosolization of bupivacaine reduces postoperative pain in laparoscopic surgery: a randomized prospective controlled double-blinded clinical trial. Surg Endosc. 2007 Apr;21(4):602-6. doi: 10.1007/s00464-006-9087-6. Epub 2006 Dec 16.
PMID: 17180268BACKGROUNDNutthachote P, Sirayapiwat P, Wisawasukmongchol W, Charuluxananan S. A randomized, double-blind, placebo-controlled trial of oral pregabalin for relief of shoulder pain after laparoscopic gynecologic surgery. J Minim Invasive Gynecol. 2014 Jul-Aug;21(4):669-73. doi: 10.1016/j.jmig.2014.01.018. Epub 2014 Jan 25.
PMID: 24473153BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Timothy Deimling, M.D.
- Organization
- Penn State Milton S. Hershey Medical Center
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator; Minimally Invasive Gyn Surgery Fellow
Study Record Dates
First Submitted
February 4, 2015
First Posted
February 9, 2015
Study Start
June 1, 2015
Primary Completion
January 1, 2017
Study Completion
January 1, 2017
Last Updated
March 12, 2018
Results First Posted
March 12, 2018
Record last verified: 2018-03